Theme

Reimbursement for medicine

Read about how much you can get in reimbursement for your medicine, which types of reimbursement you can get in Denmark, and what the rules are for the different types of reimbursement.

Go to theme
Theme

Strategy for the DKMA

The Danish Medicines Agency has formulated a strategy for 2022-26. The strategy emphasizes a vision of leading the way in national and international cooperation, and in the dialogue with citizens and society. Read more.

Go to theme
indgangsikon nr 1

General public

Here you can read about reimbursement, drugs affecting the ability to drive and other topics relevant for the general public.

indgangsikon nr 2

Industry

Information on licensing, inspections, fees, company authorisations, clinical trials and more.

indgangsikon nr 3

Healthcare professionals

This section gathers information for doctors, nurses, pharmacies, dentists and other healthcare professionals.

Report a side effect from medicines About Brexit International activities Transparency Subscribe to news in English Mission, vision and strategy Whistleblower scheme New veterinary medicinal products regulation Jobs 0

News

Status for the project regarding the control of anti-tampering devices (ATD) on medicinal product packages

25 April 2024

Information for marketing authorisation holders (MAH). The Danish Medicines Agency's laboratory is currently working on a project to check the anti-tampering device (ATD) on selected medicinal product packages. Approx. 10% of the packages requisitioned so far had an ATD that did not work. The flawed devices are designed as a sticker, that can be removed without it being visible on the packaging. We encourage marketing authorisation holders to test their ATDs to avoid unauthorised access to the medicinal products.

Danish Medicines Agency establishes that chronic urticaria could be a side effect of the Spikevax vaccine

05 April 2024

Survey on strategy for Ph. Eur. quality standards for monoclonal antibodies

11 March 2024

Regulatory training on transitional trials in CTIS with open question and answers session

13 February 2024